Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02097810 |
Title | Study of Oral RXDX-101 in Adult Patients With Locally Advanced or Metastatic Cancer Targeting NTRK1, NTRK2, NTRK3, ROS1, or ALK Molecular Alterations. (STARTRK-1) |
Acronym | STARTRK-1 |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | Yes |
Sponsors | Hoffmann-La Roche |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
UC Irvine Medical Center | Orange | California | 92868 | United States | Details | |
University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center | San Francisco | California | 94158 | United States | Details | |
University Of Colorado | Aurora | Colorado | 80045 | United States | Details | |
Georgetown University Medical Center | Washington | District of Columbia | 20007 | United States | Details | |
Florida Cancer Specialists - Sarasota | Sarasota | Florida | 34232 | United States | Details | |
Massachusetts General Hospital | Boston | Massachusetts | 02114 | United States | Details | |
Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
Tennessee Oncology | Nashville | Tennessee | 37203 | United States | Details | |
University of Texas M.D. Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
Samsung Medical Center | Seoul | 06531 | Korea, Republic of | Details |